Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Sales | 1,224 | 1,006 | 871 | 690 | 1,837 |
| Cost of Goods | 65 | 66 | 79 | 63 | 59 |
| Gross Profit | 1,159 | 940 | 792 | 627 | 1,778 |
| Operating Expenses | 1,727 | 2,225 | 1,827 | 2,142 | 2,526 |
| Operating Income | -503 | -1,219 | -956 | -1,452 | -689 |
| Interest Expense | 43 | -1,590 | 1,860 | 169 | 169 |
| Other Income | 4,627 | 21,130 | -13,725 | -8,979 | -4,034 |
| Pre-tax Income | 4,081 | 21,501 | -16,541 | -10,600 | -4,892 |
| Net Income Continuous | 4,081 | 21,501 | -16,541 | -10,600 | -4,892 |
| Net Income | $4,081 | $19,827 | $-14,867 | $-10,600 | $-4,892 |
| EPS Basic Total Ops | 175.00 | 987.50 | -787.50 | -575.00 | -275.00 |
| EPS Basic Continuous Ops | 205.69 | 1,112.50 | -855.31 | -548.41 | -253.26 |
| EPS Diluted Total Ops | 162.50 | 987.50 | -787.50 | -575.00 | -275.00 |
| EPS Diluted Continuous Ops | 202.78 | 1,112.50 | -855.31 | -548.41 | -253.26 |
| EBITDA(a) | $-502 | $-891 | $-938 | $-1,433 | $-635 |